Shionogi Increases Stake in ViiV Healthcare Through $2.125 Billion Transaction with GSK and Pfizer

Wachtell, Lipton, Rosen & Katz has advised Pfizer. Skadden has advised Shionogi. Slaughter and May has advised GSK plc. GSK plc and Shionogi & Co., Ltd…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here